More articles from Research Article

Anti-VEGF Treatment Enhances CD8+ T-Cell Antitumor Activity by Amplifying Hypoxia
Patricia E de Almeida, Judy Mak, Genevive Hernandez, Rajiv Jesudason, Aurelie Herault, Vincent Javinal, Jovencio Borneo, Jeong M Kim, Kevin Barry Walsh

Cancer Immunology Research Jan 2020, canimm.0360.2019; DOI: 10.1158/2326-6066.CIR-19-0360
CSF1R is required for differentiation and migration of Langerhans cells and Langerhans cell histiocytosis
Silvia Lonardi, Sara Scutera, Sara Licini, Luisa Lorenzi, Anna Maria Cesinaro, Luisa Benerini Gatta, Carlotta Castagnoli, Daniele Bollero, Rosaria Sparti, Michela Tomaselli, Daniela Medicina, Federica Calzetti, Marco A Cassatella, Fabio Facchetti, Tiziana Musso, William Vermi

Cancer Immunology Research Jan 2020, canimm.0232.2019; DOI: 10.1158/2326-6066.CIR-19-0232
Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
ANM Nazmul H. Khan, Tiffany R Emmons, Jerry T. Wong, Emad Alqassim, Kelly L Singel, Jaron Mark, Brandon E Smith, Joseph D. Tario, Kevin H. Eng, Kirsten B. Moysich, Kunle Odunsi, Scott I. Abrams, Brahm H Segal

Cancer Immunology Research Jan 2020, canimm.0556.2019; DOI: 10.1158/2326-6066.CIR-19-0556
Histone deacetylase inhibitors and IL21 cooperate to reprogram human effector CD8+ T cells to memory T cells
Junmei Wang, Farah Hasan, Amanda C Frey, Haiyan S. Li, Jungsun Park, Ke Pan, Cara Haymaker, Chantale Bernatchez, Dean A Lee, Stephanie S. Watowich, Cassian Yee

Cancer Immunology Research Jan 2020, canimm.0619.2019; DOI: 10.1158/2326-6066.CIR-19-0619
Excessive costimulation leads to dysfunction of adoptively transferred T cells
Dinali Wijewarnasuriya, Christina Bebernitz, Andrea V Lopez, Sarwish Rafiq, Renier J Brentjens

Cancer Immunology Research Jan 2020, canimm.0908.2019; DOI: 10.1158/2326-6066.CIR-19-0908
Donor lymphocyte-derived natural killer cells control major histocompatibility complex class I-negative melanoma
Nana Dang, Yuan Lin, Mark Waer, Ben Sprangers

Cancer Immunology Research Jan 2020, canimm.0666.2019; DOI: 10.1158/2326-6066.CIR-19-0666
Optimization of T-cell receptor-modified T cells for cancer therapy
Dylan J. Drakes, Sarwish Rafiq, Terence J Purdon, Andrea V Lopez, Smita S. Chandran, Christopher A. Klebanoff, Renier J Brentjens

Cancer Immunology Research Jan 2020, canimm.0910.2019; DOI: 10.1158/2326-6066.CIR-19-0910
Inhibition of MICA and MICB Shedding Elicits NK cell-mediated Immunity against Tumors Resistant to Cytotoxic T cells
Lucas Ferrari de Andrade, Sushil Kumar, Adrienne Luoma, Yoshinaga Ito, Pedro Henrique Alves da Silva, Deng Pan, Jason W Pyrdol, Charles H. Yoon, Kai W Wucherpfennig

Cancer Immunology Research Jan 2020, canimm.0483.2019; DOI: 10.1158/2326-6066.CIR-19-0483
Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells
Gennaro Prota, Uzi Gileadi, Margarida Rei, Ana Victoria Lechuga-Vieco, Ji-Li Chen, Silvia Galiani, Melissa Bedard, Vivian Wing Chong Lau, Lorenzo F Fanchi, Mara Artibani, Zhiyuan Hu, Siamon Gordon, Jan Rehwinkel, Jose A Enríquez, Ahmed A Ahmed, Ton N Schumacher, Vincenzo Cerundolo

Cancer Immunology Research Jan 2020, canimm.0467.2019; DOI: 10.1158/2326-6066.CIR-19-0467
A PSMA-targeting CD3 bispecific antibody induces antitumor responses that are enhanced by 4-1BB costimulation
Danica Chiu, Richard Tavaré, Lauric Haber, Olulanu H Aina, Kristin Vazzana, Priyanka Ram, Makenzie Danton, Jennifer Finney, Sumreen Jalal, Pamela Krueger, Jason T. Giurleo, Dangshe Ma, Eric Smith, Gavin Thurston, Jessica R. Kirshner, Alison Crawford

Cancer Immunology Research Jan 2020, canimm.0518.2019; DOI: 10.1158/2326-6066.CIR-19-0518

Main menu

User menu

Search

More articles from Research Article

Pages

Articles

Info for

About Cancer Immunology Research